fetal - Suchergebnis
Meldungen sortieren nachRelevanzMeldungsdatum
 |
InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma
03.03.2010, 14:23 Uhr, Biotechnik, InVitria
InVitria's launch of Zap-Hybridoma provides a powerful solution for hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity...
 |
InVitria Presents Zap-CHO Performance Results at PEACe Conference
24.09.2009, 10:28 Uhr, Biotechnik, InVitria
Zap-CHO: a new and innovative CHO cell culture supplement from InVitria designed to deliver superior growth, maximum antibody productivity and faster cell line development....
 |
QIAGEN and Sequenom Enter Into a Collaboration Targeting Prenatal Diagnostics
08.01.2007, 10:56 Uhr, Forschung und Entwicklung, QIAGEN GmbH
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. (Nasdaq: QGEN, Frankfurt, Prime Standard: QIA) and Sequenom, Inc. (Nasdaq: SQNM) today announced that they...
|
InVitria Sponsors ESACT 2009 in Dublin, Ireland
05.06.2009, 14:34 Uhr, FirmenIntern, InVitria
InVitria, a leading supplier of performance enhancing cell culture media supplements, to sponsor the 21st Meeting of the European Society for Animal Cell Technology...
|
InVitria Reveals Technology to Optimize Hybridoma Production Performance
27.04.2009, 14:14 Uhr, Biotechnik, InVitria
Recent studies using both classical media and the leading commercial serum-free hybridoma media formulations proved that InVitria's cell culture supplements optimized...
 |
Neuroproof® GmbH and Brinkhaus Life Science (www.biotech-alliances.com) present screening technology in California/USA
06.05.2009, 12:07 Uhr, FirmenIntern, Dr. Frank Brinkhaus Life Science Consulting
NeuroProof® GmbH of Rostock/Germany (www.neuroproof.com) presented its screening technology, which is used for preclinical development of neuroactive drugs and safety...
 |
Roche NimbleGen CGH Arrays Enable Detection of the Genomic Disorder Resulting in Diabetes
01.08.2008, 18:12 Uhr, Biotechnik, Roche Diagnostics GmbH
Chromosomal rearrangements leading to genomic disorders are often mediated by low-copy repeat regions of the genome (e.g. segmental duplications). Roche NimbleGen...
 |
ISPro und MEDNOVO kooperieren
11.04.2007, 10:49 Uhr, Kooperationen / Fusionen, CompuGROUP Holding AG
Die ISPro GmbH aus Hattingen und die MEDNOVO GmbH & Co. KG Medical Software Solutions aus Berlin haben im April 2007 eine Kooperation bei der Kopplung der Telematikplattform...
 |
Medical imaging equipment OEMs can achieve faster, more accurate results with TI's portfolio of embedded processors and analog products
12.11.2008, 16:00 Uhr, Hardware, Texas Instruments Deutschland GmbH
Texas Instruments [NYSE: TXN] (TI) today announced a portfolio of more than 15 dedicated embedded processors which enable faster, more accurate results for doctors...
Veröffentlichungsdatum
Firmen
Kategorien
- Biotechnik (4)
- FirmenIntern (2)
- Forschung / Entwicklung (1)
- Hardware (1)
- Kooperationen / Fusionen (1)
Alle Kategorien
Fehlertoleranz
Pressearchiv
Ergebnis aus Gesamtarchiv 
